InvestorsHub Logo
Followers 11
Posts 867
Boards Moderated 0
Alias Born 05/18/2013

Re: None

Sunday, 09/27/2015 12:52:27 PM

Sunday, September 27, 2015 12:52:27 PM

Post# of 2099
Buyout candidate by Roche!!

Better safety and tolerability than their product Avastin. Would not surprise me in the least to see a buyout before year end to hold their market position and maintain their profit in these drugs. If not, VBLT will eat their lunch with VB-111 6 billion a year market for brain, thyroid and ovarian cancer and many others it has not been tested against.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News